Friday, October 8, 2021

2 Indian Firms Seek To End Current Trials Of Merck's Anti-Covid Pill

Two drugmakers in the country have requested permission to end their late-stage trials on Merck & Co's experimental antiviral drug molnupiravir in moderate COVID-19 patients.

No comments:

Post a Comment

Top Court Directs UPSC To Allow Scribe Change Up To 7 Days Before Exam

The Supreme Court directed the Union Public Service Commission (UPSC) on Wednesday to incorporate in the notification for examinations a pro...